Fri, 30 June 2023
Type of Secondary Transactions Hello, this is Hall T. Martin with the Startup Funding Espresso -- your daily shot of startup funding and investing. There are several types of secondary transactions as follows: Confidentially marketed public offerings -- these offerings go to institutional investors. These transactions use an S3 form to provide shares to known buyers. Bought deal -- these shares are bought by an underwriter who takes the risk of the transaction. Since the risk is shouldered by one underwriter the shares are typically priced higher. PIPEs -- these are Private Investments in Public Entities and give private investors the ability to buy shares directly in the company without public disclosure. PIPEs are more heavily discounted. Block trades -- these are transactions used by smaller sellers to sell their shares directly to another buyer without having to go through an underwriter. These transactions provide alternative ways of completing a secondary sale.
Thank you for joining us for the Startup Funding Espresso where we help startups and investors connect for funding. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound. |
Fri, 30 June 2023
We are excited to announce a new segment for you, How to Invest Series. Where we will be revisiting some of the smart insights, tips, and advice from our past guests on the show. To start off the series we will be touching on the Biotech and life science subject. So, let's dive right in and hear the answers to the question I made to each of our guests back in 2021: What makes for a successful company in this segment? Our first five guests are: Carter Williams, CEO and Managing Partner of iSelect Fund, Maximilian Bade, Founding Partner at Nucleus Capital, Orrin Ailloni-Charas, MD, who was the Managing Partner of the Global Health Impact Fund, Eyal Lifschitz, Co-Founder and Managing Partner at Peregrine Ventures, and Ron Paliwoda, President of the Paliwoda Group. Carter Williams, a seasoned innovator and venture investor, has an extensive background in managing R&D and spearheading technological advancements. Currently, Carter leads iSelect, an early-stage venture firm based in St. Louis, which focuses on investing in companies tackling global issues with financially attractive business models. Maximilian has founded Nucleus Capital to support purpose-driven entrepreneurs addressing systemic challenges to planetary health. Nucleus Capital is a venture capital firm focused on investing in pre/seed stage companies at the intersection of synthetic biology, climate- and food technology. Dr. Orrin Ailloni-Charas is an experienced anesthesiologist and investment leader, with a diverse background in healthcare. In 2021, he was the CEO and Managing Partner of the Global Health Impact Fund (GHIF), a physician-led venture fund. Eyal, is an experienced entrepreneur and VC partner, with over 20 years of experience managing and investing in healthcare companies. Peregrine Ventures is a leading Israeli capital fund focused on high-tech companies in the life sciences, pharma, and digital health. Ron Paliwoda is an accidental entrepreneur and seasoned investor, primarily through the Ventures arm of The Paliwoda Group. Links from today's show: iSelect Fund: www.iselectfund.com; Nucleus Capital: www.nucleus-capital.com; Global Health Impact Fund: globalhealthimpactfund.com/; Peregrine Ventures: www.peregrinevc.com/; Paliwoda Group: www.paliwoda.com. _______________________________________________________ For more episodes from Investor Connect, please visit the site at: http://investorconnect.org Check out our other podcasts here: https://investorconnect.org/ For Feedback please contact info@tencapital.group Please follow, share, and leave a review. Music courtesy of Bensound. |